Skip to main content
SpringerLink
Log in

Chemotherapy for Advanced Osteogenic Sarcoma and Ewing’s Sarcoma

  • Conference paper
Book cover Current Concepts of Diagnosis and Treatment of Bone and Soft Tissue Tumors

  • 93 Accesses

Abstract

Malignant bone and cartilage tumors account for less than l% of all malignant neoplasms. Osteogenic sarcoma is the most common primary malignant neoplasm of bone, most frequently occurring in the diaphysis, especially in the femur. The incidence of osteogenic sarcoma peaks between ten and 25 years of age. Although many of the patients with osteogenic sarcoma present with clinically localized disease, the five-year survival rate for osteogenic sarcoma achieved with local treatment alone (surgical excision or amputation, radiation therapy, or both) is only about 20%. Preoperative radiation and surgery does not improve survival over surgery alone. In 1972, Friedman and Carter reviewed 17 reported series of patients with osteosarcoma and found a five-year survival ranging from 16–23% (Friedman and Carter, 1972). Some have suggested that the five-year disease-free survival after surgery alone has been raised to 50% (Carter and Friedman, 1978; Taylor et al, 1978). This has, however, been disputed and the figure of 20% remains generally accepted (Gehan et al, 1978; Mike and Marcove, 1978). The 10-year survival after surgery alone is 16% so that most patients who survive to five years may be regarded as cured. The natural history of osteogenic sarcoma does not appear to have changed over the past several decades (Mike and Marcove, 1978; Jaffe et al, 1974; Harvei and Solheim, 1981). The mean time to the appearance of pulmonary metastases — the most common metastases — after surgery is 10 months (Friedman and Carter, 1972). Before the 1970’s, the average time between the recognition of pulmonary metastases and death was six months (Friedman and Carter, 1972). These survival and natural history variables provide consistent clean end points which may be used in judging the effectiveness of new therapies for osteogenic sarcoma. The rapid clinical appearance of distant metastatic disease has led many clinical investigators to conclude that most patients present with distant micrometastases which are not clinically evident at the time of their initial diagnosis. It is therefore expected that these patients will fail when given local therapy only.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baum, E.S., Gagnon, P., Greenberg, L., Krivit, W., and Hammond, D.: Phase II study of cis-Dichlorodiammineplatinum (II) in childhood osteosarcoma: Children’s Cancer Study Group Report. Cancer Treat. Rep. 63, 1621, 1979.

    PubMed  CAS  Google Scholar 

  2. Bonadonna, G., Gasparini, M., Rouesse, J., Van Oosterom, A., Wagener, T., Voute, T., Thomas, P. and Sylvester, R.: Phase II study of CDDP in advanced osteogenic sarcoma (OS). Proc. Am. Soc. Clin. Oncol. 2, 240, 1983.

    Google Scholar 

  3. Carter, S.K. and Friedman, M.: Osteogenic sarcoma treatment overview and some comments on interpretations of clinical trial data. Cancer Treat. Rep. 62, 199, 1978.

    PubMed  CAS  Google Scholar 

  4. Chan, R.C., Sutow, W.W., Lindberg, R.D., Samuels, M.L., Murray, J.A., and Johnston, D.A.: Management and results of localized Ewing’s sarcoma. Cancer 43, 1001, 1979.

    Article  PubMed  CAS  Google Scholar 

  5. Cortes, E.P., Holland, J.F., Wang, J.J. and Sinks, L.F.: Doxorubicin in disseminated osteosarcoma. JAMA 221, 1132, 1972.

    Article  Google Scholar 

  6. Cortes, E.P., Holland, J.F., Wang, J.J., and Glidwell, O.: Adriamycin (NSC-123127) in 87 patients with osteosarcoma. Cancer Chern. Rep. 6, 305, 1975.

    Google Scholar 

  7. Ettinger, L.J., Douglass, H.O. Jr., Higby, D.J., et al: Adriamycin (Adria) and cis-diamminedichloroplatinum (CDDP) as adjuvant therapy in primary osteosarcoma (OS). Proc. Am. Assoc. Cancer Res. 20, 438, 1979.

    Google Scholar 

  8. Evans, A.E.: Mitomycin C. Cancer Chern. Rep. 14, 1, 1961.

    CAS  Google Scholar 

  9. Friedman, M.A., and Carter, S.K.: The therapy of osteogenic sarcoma: current status and thoughts for the future. J. Surg. Oncol. 4, 482, 1972.

    Article  PubMed  CAS  Google Scholar 

  10. Gehan, E. A., Sutow, W. W., and Uribe-Botero, G.: Osteosarcoma: M.D. Anderson experience, 1950–1974. Prog. Cancer Res. Ther. 6, 271, 1978.

    Google Scholar 

  11. Gottlieb, J.A., Baker, L.H., Quagliana, J.M., Luce, J.K., Whitecar, J.P.Jr., et al: Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer 30, 1632, 1972.

    Article  PubMed  CAS  Google Scholar 

  12. Gottlieb, J.A., Baker, L.H., O’Bryan, R.M., Sinkovics, J.G., Hoogstraten, B., et al: Adriamycin (NSC-123127) used alone or in combination for soft tissue and bony sarcomas. Cancer Chern. Rep. 6, 271, 1975.

    Google Scholar 

  13. Harvei, S., and Solheim, O.: The prognosis in osteosarcoma. Norwegian national data. Cancer 48, 1719, 1981.

    Article  PubMed  CAS  Google Scholar 

  14. Hustu, H.O., Pinkel, D., and Pratt, C.B.: Treatment of clinically localized Ewing’s sarcoma with radiotherapy and combination chemotherapy. Cancer. 6, 1533, 1972.

    Google Scholar 

  15. Jaffe, N., Farber, s., Traggis, D., Geiser, c., Kim, B.S., Dass, L., Frauenberger, G., Djerassi, I∼ and Cassady, J.R.: Favorable response of metastatic osteogenic sarcoma to high-dose methatrexate with citrovorum rescue and radiation therapy. Cancer 31, 1367, 1973.

    Article  PubMed  CAS  Google Scholar 

  16. Jaffe, N., Frei, E. III, Traggis, D., and Bishop, Y.: Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N. Engl. J. Med. 291, 994, 1974.

    Article  PubMed  CAS  Google Scholar 

  17. Jaffe, N.J., Traggis, D., Salian, S., and Cassady, J.R.: Improved outlook for Ewing’s sarcoma with combination chemotherapy (vincristine, actinomycin-D and cyclophosphamide) and radiation therapy. Cancer 38, 19251 1976.

    Google Scholar 

  18. Jaffe, N., Frei, E. III, Traggis, D., and Watts, H.: Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma. Pre-surgical treatment of primary tumor and of overt pulmonary metastases. Cancer 39, 45, 1977.

    Article  PubMed  CAS  Google Scholar 

  19. Jaffe, N., Knapp, J., Chuang, V.P., Wallace, S., Ayala, A., Murray, J., Cangir, A., Wang, A., and Benjamin, R.S.: Osteosarcoma: intra-arterial treatment of the primary tumor with Cis-Diammine-Dichloroplatinum (COP). Cancer 51, 402, 1983.

    Article  PubMed  CAS  Google Scholar 

  20. Lange, B., Kramer, S., Gregg, J.R., Toledano, S., Wimmer, R., and Evans, A.E.: High-dose methotrexate and adriamycin in osteogenic sarcoma. The Children’s Hospital of Philadelphia study. Am. J. Clin. Oncol. 5, 3, 1982.

    PubMed  CAS  Google Scholar 

  21. Levine, A.S., Appelbaum, R.G., Graw, R.G., Magrath, I.T., Pizzo, P.A., Poplack D.G., and Ziegler, J.L.: Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastatic osteogenic sarcoma. Cancer Treat. Rep. 62, 247, 1978.

    PubMed  CAS  Google Scholar 

  22. Mike, V., and Marcove, R.C.: Osteogenic sarcoma under the age of 21: experience at Memorial Sloan-Kettering Cancer Center. Prog. Cancer Res. Ther. 6, 283, 1978.

    Google Scholar 

  23. Mosende, C., Gutierrez, M., Caparros, B., and Rosen, G.: Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma. Cancer 40, 2779, 1977.

    Article  PubMed  CAS  Google Scholar 

  24. Ochs, J.J., Freeman, A.I., Douglass, H.O., Higby, D.S., Mindell, E.R., and Sinks, L.F.: cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma. Cancer Treat. Rep. 62, 239, 1978.

    PubMed  CAS  Google Scholar 

  25. Oldham, R.K., and Pomeroy, T.C.: Treatment of Ewing’s sarcoma with adriamycin. Cancer Chern. Rep. 56, 635, 1972.

    CAS  Google Scholar 

  26. Perez, C., Herson, J., Kimbal, J.C., and Sutow, W.W.: Prognosis after metastases in osteosarcoma. Cancer Clin. Trials 1, 315, 1978.

    PubMed  CAS  Google Scholar 

  27. Pilepich, M.V., Vietti, T.J., Nesbit, M.E., Tefft, M., Kissane, J., Burgert, E.O., and Pritchard, D.: Radiotherapy and combination chemotherapy in advanced Ewing’s sarcoma. Cancer 47, 1930, 1981.

    Article  PubMed  CAS  Google Scholar 

  28. Pratt, C.B.: Chemotherapy of osteosarcoma- an overview. In, Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas. Eds., A.T. Van Oosterom et al. Martinus Nijhoff Publishers. The Hague, 1980.

    Google Scholar 

  29. Pratt, C.B., Howarth, C., Ransom, J.L., Bowles, D., Green, A.A., Kumar, A.P.M., Rivera, G., and Evans, W.E.: High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma. Cancer Treat. Rep. 64, 11, 1980.

    PubMed  CAS  Google Scholar 

  30. Rosen, G.: Current management of malignant bone sarcomas. In, Cancer. Achievements, Challenges and Prospects for the 1980s. Eds., J.H. Burchenal and H.F. Oettgen. Gruen and Stratton, New York, 1981.

    Google Scholar 

  31. Rosen, G., Suwansirikal, S., Kwon, C., Tan, C., Wu, S.J., Beattie, E.J., Jr., and Murphy, M.L.: High-dose methotrexate and citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer 33. 1151, 1974.

    Article  PubMed  CAS  Google Scholar 

  32. Rosen, G., Caparros, B., Mosende, C., McCormick, B., Huvos, A.G., and Marcove, R.C.: Curability of Ewing’s sarcoma and considerations for future therapeutic trials. Cancer 41, 888, 1978.

    Article  PubMed  CAS  Google Scholar 

  33. Rosen, G., and Nirenberg, A.: Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe. Cancer Treat. Rep. 66, 1687, 1982.

    PubMed  CAS  Google Scholar 

  34. Senyszy, J.J., Johnson, R.E., and Curran, R.E.: Treatment of metastatic Ewing’s sarcoma with actinomycin-D (NSC-3053). Cancer Chemo. Rep. 54, 103, 1970.

    Google Scholar 

  35. Sullivan, M.P., and Sutow, W.W.: Phenylalanine mustard as a treatment for metastatic osteogenic sarcoma in children. J. Ped. 63, 227, 1963.

    Article  CAS  Google Scholar 

  36. Sutow, W.W., Vietti, T.J., Fernback, D.J., Lane, D.M., and Lonsdale, D.: Evaluation of chemotherapy in children with metastatic Ewing’s sarcoma and osteogenic sarcoma. Cancer Chern. Rep. 55, 67, 1971.

    CAS  Google Scholar 

  37. Taylor, W.E., Ivins, J.C., and Dahlin, D.C.: Trends and variability in survival from osteosarcoma. Mayo Clin. Proc. 53, 695, 1978.

    PubMed  CAS  Google Scholar 

  38. Tepper, J., Glaubiger, D., Lichter, A., Wackenhut, J., and Glatstein, E.: Local control of Ewing’s sarcoma of bone with radiotherapy and combination chemotherapy. Cancer 9, 1969, 1980.

    Article  Google Scholar 

  39. Vietti, T.J., Gehan, E.A., Nesbit, M.E. Jr., Burgert, E.O. Jr., Pilepich, M., Tefft, M., Kissane, J., and Pritchard, D.J.: Multimodal therapy in metastatic Ewing’s sarcoma: An intergroup study. Nat. Cancer Inst. Monograph 56, 279, 1981.

    Google Scholar 

  40. Weichselbau, R.R., Cassady, J.R., Jaffe, N., and Filler, R.M.: Preliminary results of aggressive multimodality therapy for metastatic osteosarcoma. Cancer 40, 78, 1977.

    Article  Google Scholar 

Download references

Authors
  1. B. Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. E. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Orthopaedics, Faculty of Medicine, University of Ottawa, Canada

    Hans K. Uhthoff MD, FRCS(C) (Prof. and Head) (Prof. and Head)

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hernandez, B., Harris, J.E. (1984). Chemotherapy for Advanced Osteogenic Sarcoma and Ewing’s Sarcoma. In: Uhthoff, H.K. (eds) Current Concepts of Diagnosis and Treatment of Bone and Soft Tissue Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69210-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69210-9_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69212-3

  • Online ISBN: 978-3-642-69210-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation